Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows an added Revision: v3.5.0 and a removed Revision: v3.4.3. This appears to be an administrative versioning update rather than a modification to the study data or content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site revision was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check58 days agoChange DetectedPrimary outcome maintenance phase wording updated to 'Baseline through Week 48' from 'post-randomization through Week 48'.SummaryDifference0.3%

- Check65 days agoChange DetectedThe change is a minor revision update from v3.4.1 to v3.4.2; no substantive content changes are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision label v3.4.1 was added and the previous revision v3.4.0 was removed. This appears to be a cosmetic/versioning update that does not change study content or user-facing information on the page.SummaryDifference0.1%

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.